Matching: For each inborn error of amino acid metabolism, select the correct urine odor - Phenylketonuria
Rationale:
Phenylketonuria has a distinctive hoplike odor in the urine. This characteristic scent arises from the accumulation of phenylalanine and its metabolites due to the body's inability to properly metabolize this amino acid.
A: Cabbage This smell is associated with other metabolic disorders, particularly those involving sulfur-containing compounds, not with phenylketonuria, which specifically produces a different odor profile.
C: Sweaty The sweaty odor typically indicates other metabolic issues, such as maple syrup urine disease, rather than the hoplike scent characteristic of phenylketonuria's metabolic dysfunction.
A 5-day-old infant manifests tachypnea, poor feeding, vomiting, and decreased responsiveness. A sepsis workup is performed, and the child is started on a D10W infusion and receives ampicillin and cefotaxime. The condition worsens, and the child becomes unresponsive to stimuli. All cultures are negative after 48 hours. The arterial blood gas is 7.45, PCO2 36, PO2 100, the anion gap is normal, the blood glucose is 75 mg/dL, and serum ammonia is 500 μM. The most likely diagnosis is
Rationale:
B: urea cycle defect. The infant's elevated ammonia level, combined with neurological deterioration and negative cultures, strongly indicates a metabolic disorder affecting ammonia detoxification, typical of a urea cycle defect.
A: congenital hyperinsulinism with hyperammonemia. This condition primarily features hypoglycemia and does not typically present with elevated ammonia, nor does it explain the infant's severe neurological symptoms.
C: methylmalonic acidemia. While this condition can lead to metabolic derangements, it usually presents with metabolic acidosis and specific urine organic acids, which are not indicated in this case.
D: maple syrup urine disease. This disorder usually causes feeding difficulties and neurological symptoms, but it specifically leads to elevated branched-chain amino acids rather than isolated hyperammonemia as seen here.
A 2-year-old girl presented with rapid deep breathing, hypoglycemia, recurrent epistaxis, easy bruising, failure to thrive, fat cheek, and hepatomegaly. Of the following, the MOST likely cause of bleeding tendency is
Rationale:
C: Impaired hepatic function. The girl's symptoms, including easy bruising and hepatomegaly, suggest liver dysfunction, which affects the synthesis of clotting factors, leading to a bleeding tendency.
A: vascular disorders. While vascular issues can contribute to bleeding, the symptoms presented strongly indicate liver impairment as the primary source of the bleeding tendency.
B: clotting factors deficiency. Although deficiencies can cause bleeding, the context points towards hepatic dysfunction affecting clotting factor production, rather than an isolated deficiency.
D: depressed platelets count. Low platelet counts can result in bleeding, but the clinical picture emphasizes liver issues, which are more directly linked to her symptoms and bleeding tendency.
Acquired hypogonadotropic hypogonadism include
Rationale:
Acquired hypogonadotropic hypogonadism includes chemotherapy. Chemotherapy directly affects the hypothalamic-pituitary-gonadal axis, leading to reduced hormone production and impaired reproductive function, which classifies it as an acquired form of hypogonadotropic hypogonadism.
B: malnutrition Malnutrition primarily impacts overall health and nutrient absorption, rather than specifically targeting the hormonal pathways involved in hypogonadotropic hypogonadism.
C: cystic fibrosis Cystic fibrosis is a genetic condition that affects the lungs and digestive system, not directly causing hypogonadotropic hypogonadism through hormonal disruption.
D: infection (e.g., mumps) While infections can lead to hypogonadism, mumps specifically causes orchitis rather than directly limiting hormone production through the hypogonadal axis.
A painless nodule in the thyroid or in the neck is the usual presentation of childhood thyroid cancer. Of the following, the MOST common site of distant metastasis is
Rationale:
D: The lungs are the most common site of distant metastasis in childhood thyroid cancer, as the cancer cells typically spread hematogenously, favoring pulmonary tissue due to its extensive blood supply.
A: mediastinum: Metastasis to the mediastinum occurs, but it is less frequent than lung involvement, as thyroid cancer preferentially targets the lungs for spread.
B: long bones: While metastasis can occur in long bones, this site is not as common as the lungs, which are a primary target for thyroid cancer spread.
C: skull: The skull can be involved in metastasis, yet the frequency is significantly overshadowed by lung metastases, which are more typical for this type of cancer.
Matching: Glycogen storage diseases - Pompe
Rationale:
Pompe disease is characterized by cardiomegaly and hypotonia, stemming from the accumulation of glycogen in the heart and skeletal muscles. This leads to severe muscle weakness and heart enlargement, key symptoms of the condition.
A: Muscle cramps, exercise intolerance. These symptoms are more typical of myopathies related to metabolic disorders but do not specifically identify Pompe disease's hallmark features.
B: Severe hypoglycemia, hepatomegaly. These signs are associated with other glycogen storage diseases, particularly those affecting liver metabolism, and do not reflect the cardiac and muscular symptoms of Pompe disease.
D: Progressive early cirrhosis, failure to thrive. While these are serious conditions, they are indicative of other metabolic disorders rather than the specific manifestations of Pompe disease, which focus on cardiac and muscular issues.
Patients with mineralocorticoid deficiency can develop the following EXCEPT
Rationale:
Patients with mineralocorticoid deficiency can develop metabolic alkalosis.
This is accurate as mineralocorticoid deficiency typically leads to electrolyte imbalances, including sodium loss and potassium retention, which can cause metabolic acidosis instead of alkalosis.
A: weight loss Excessive fluid loss and altered metabolism in these patients often result in unintended weight reduction.
B: hypotension Low mineralocorticoid levels can cause inadequate sodium reabsorption, leading to decreased blood volume and resultant hypotension.
D: hyponatremia Sodium retention is compromised in mineralocorticoid deficiency, leading to low serum sodium levels, known as hyponatremia.
Matching: Peroxisomal disorder
Rationale:
Peroxisomal disorder. This term encompasses a group of genetic conditions characterized by dysfunction in peroxisomes, organelles responsible for lipid metabolism and detoxification, leading to a variety of metabolic issues and health challenges.
B: Disorder of peroxisomal import. This phrase specifies a subset of peroxisomal disorders, focusing on import mechanisms rather than the broader classification of peroxisomal dysfunctions affecting multiple metabolic pathways.
C: X-linked. This designation refers to genetic conditions linked to the X chromosome but does not encompass all peroxisomal disorders, which can be inherited through various genetic patterns.
D: Primarily African-American. While certain peroxisomal disorders may have demographic trends, this classification inaccurately suggests a racial limitation, ignoring the global prevalence and genetic diversity of these disorders.
The percentage of individuals with congenital heart defects is highest in
Rationale:
B: The percentage of individuals with congenital heart defects is highest in Williams syndrome. This condition is characterized by a distinct set of cardiovascular anomalies, making it the most prevalent among congenital heart defect cases compared to other syndromes listed.
A: Turner syndrome presents various health challenges, yet the prevalence of congenital heart defects is lower compared to Williams syndrome. Cardiovascular issues exist, but not as prominently.
C: Down syndrome features a range of congenital conditions, including heart defects, but these occur with less frequency than in Williams syndrome. The specific heart-related issues are different in nature and prevalence.
D: Cri du Chat syndrome is associated with multiple developmental and health issues, but congenital heart defects are less common. This syndrome primarily affects other systems rather than showing a high incidence of heart defects.
A 6-week-old infant has gained no weight since birth. She is mottled and has an indirect bilirubin level of 24 mg/dL. Her extremities are cold, and her temperature is 35°C. The most likely diagnosis is
Rationale:
Hypothyroidism. The infant's lack of weight gain, mottled appearance, cold extremities, and low temperature indicate a potential metabolic disorder. Hypothyroidism can lead to these symptoms, particularly in newborns, necessitating prompt diagnosis and treatment.
A: kernicterus. This condition refers to bilirubin-induced neurological damage, typically presenting with jaundice but not primarily characterized by the significant weight loss and hypothermia observed in this case.
B: sepsis. While sepsis could lead to poor feeding and temperature instability, the specific combination of symptoms and elevated bilirubin levels points more directly to hypothyroidism rather than an infectious process.
C: galactosemia. This metabolic disorder causes failure to thrive and jaundice but does not typically present with the cold extremities and hypothermia seen in this infant, making it less likely.
A 12-year-old female has a hypoglycemic seizure, weakness, and increased cutaneous pigmentation. She is also noted to have a chronic history of mucocutaneous candidiasis, which is especially severe on her nails. In addition, she has been on thyroid replacement medication since the age of 9 years. The most likely diagnosis is
Rationale:
Autoimmune polyendocrinopathy. This diagnosis aligns with the patient's symptoms, including hypoglycemic seizures, increased pigmentation, and severe candidiasis, indicating an autoimmune condition affecting multiple endocrine glands and immune response.
A: insulinoma Excessive insulin production typically leads to hypoglycemia, but it does not explain the accompanying symptoms like candidiasis or pigmentation changes, which are indicative of an autoimmune process.
B: growth hormone deficiency This condition primarily affects growth and metabolism, lacking the diverse symptoms presented, such as mucocutaneous candidiasis and pigmentation, which point towards an autoimmune disorder.
C: AIDS The symptoms described do not specifically correlate with AIDS, which is characterized by immune deficiency rather than the specific endocrine and candidiasis issues seen in this case.
Reported side effects of GH treatment include the following EXCEPT
Rationale:
D: A 6-fold increase in the risk for type 1 diabetes is not a reported side effect of growth hormone treatment, distinguishing it from the other mentioned side effects, which are documented.
A: Pseudotumor cerebri involves increased intracranial pressure and is a recognized complication linked to growth hormone therapy, highlighting its potential neurological effects on patients undergoing treatment.
B: Slipped capital femoral epiphysis is a known risk associated with growth hormone therapy, particularly in adolescents, as it affects the hip joint and can lead to significant mobility issues.
C: Gynecomastia, the enlargement of breast tissue in males, is documented as a side effect of growth hormone treatment, reflecting hormonal changes that can occur during therapy.
The following criteria are needed for the diagnosis of syndrome of inappropriate secretion of antidiuretic hormone (SIADH) EXCEPT
Rationale:
Hyponatremia with normal serum osmolality is not a criteria needed for the diagnosis of SIADH. Instead, SIADH typically presents with hyponatremia accompanied by low serum osmolality, indicating fluid overload and inappropriate antidiuretic hormone secretion.
A: excessive urinary sodium concentration. This criterion is relevant as SIADH often results in high urinary sodium levels due to the retention of water and dilutional effects.
C: elevated urine osmolality. High urine osmolality is a hallmark of SIADH, reflecting the kidneys' inability to excrete excess water due to inappropriate ADH secretion.
D: normal renal, adrenal, and thyroid function. This criterion is essential for diagnosing SIADH, as underlying conditions or dysfunctions in these organs could lead to similar symptoms and misinterpretation of the diagnosis.
A 16-year-old male has a tall stature but no facial, axillary, or pubic hair. His penis and scrotum are obscured by pubic adipose tissue, but they appear infantile. Chromosome analysis reveals XY karyotype. His serum follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels are elevated. The most likely diagnosis is
Rationale:
Primary hypogonadism is the most likely diagnosis. The elevated FSH and LH levels indicate a lack of testosterone production from the testes, leading to the observed delayed sexual development and tall stature.
A: galactosemia This condition primarily affects carbohydrate metabolism and does not relate to sexual development or hormone levels, making it irrelevant to the patient’s symptoms.
C: adrenal hyperplasia While this condition can affect hormone levels, it typically presents with signs of androgen excess, which is inconsistent with the observed lack of secondary sexual characteristics.
D: Noonan syndrome This genetic disorder can present with short stature and other features, but it does not typically cause the specific hormone profile and infantile genitalia seen in this case.
Hypocalcemia is common in neonates between 12 and 72 hr of life, especially in infants with
Rationale:
Hypomagnesemia is common in neonates between 12 and 72 hr of life, especially in infants with this condition. Low magnesium levels can disrupt calcium homeostasis, leading to hypocalcemia, particularly in vulnerable neonatal populations.
A: birth asphyxia This condition primarily affects oxygen delivery and may lead to neurological issues but is not directly linked to calcium regulation disturbances.
B: sepsis While sepsis can cause numerous metabolic derangements, it is not specifically associated with the development of hypocalcemia in neonates.
C: exchange transfusion This procedure is performed to address severe anemia or hyperbilirubinemia and does not inherently cause hypocalcemia in neonates.
All the following drugs are unsafe in acute intermittent porphyria EXCEPT
Rationale:
A: Nifedipine. Nifedipine is considered safe for patients with acute intermittent porphyria as it does not exacerbate the condition, unlike the other listed medications that can trigger porphyric crises.
B: Diclofenac. Diclofenac can provoke acute porphyria attacks, making it unsuitable for individuals with this condition due to its potential to increase porphyrin production.
C: Cimetidine. Cimetidine carries a risk of triggering acute intermittent porphyria episodes, thus making it an inappropriate choice for patients suffering from this metabolic disorder.
D: Valproic acid. Valproic acid is contraindicated in acute intermittent porphyria as it has been shown to induce porphyrin synthesis, increasing the likelihood of acute attacks in affected individuals.
All the following are features of neonatal adrenoleukodystrophy (ALD) EXCEPT
Rationale:
D: Chondrodysplasia punctata is not a feature of neonatal adrenoleukodystrophy (ALD), which primarily affects the adrenal glands and nervous system, leading to symptoms such as neurological decline and organ dysfunction.
A: Hepatomegaly manifests in ALD, as liver enlargement is commonly observed due to the accumulation of very long-chain fatty acids affecting organ function and metabolism.
B: Impaired liver function is characteristic of ALD, resulting from the liver's inability to process fatty acids effectively, which contributes to the overall disease pathology.
C: Severely impaired hearing can occur in ALD but is not a primary feature, as the disorder primarily impacts neurological function rather than auditory capabilities.
You are going to treat a 7-year-old boy with type 1 diabetes mellitus who develops DKA due to a recent infection. Examination reveals severe dehydration and deep acidotic breathing. Lab investigations shows: blood glucose, 450 mg/dL; blood pH, 7.2; and serum bicarbonate concentration, 14 mEq/L. Which of the following should be avoided during the treatment of this girl?
Rationale:
C: Bicarbonate administration can lead to paradoxical cerebral acidosis in children with DKA. The underlying metabolic derangement requires careful correction of acidosis through hydration and insulin therapy rather than bicarbonate supplementation, which can be harmful.
A: Lactated Ringer solution may not provide sufficient sodium or glucose needed for rapid correction of metabolic derangements in DKA, potentially delaying recovery and exacerbating the child's condition.
B: Glucose supplementation could worsen the hyperglycemia present in DKA, complicating the treatment process. Effective management requires insulin to reduce blood glucose levels rather than adding more glucose to the system.
D: Fast-acting soluble insulin is crucial for treating DKA; avoiding it would prevent necessary metabolic correction. Insulin facilitates glucose uptake and addresses the underlying hyperglycemic state essential for recovery.
Chronic lymphocytic thyroiditis is the most common cause of acquired hypothyroidism, with or without goiter. All the following are true EXCEPT
Rationale:
Chronic lymphocytic thyroiditis is characterized by a variable clinical course that can fluctuate significantly over time, making D the only statement that does not accurately reflect the condition's nature.
A: more common in girls. This condition disproportionately affects females, indicating a significant gender bias in its prevalence, which is a well-documented epidemiological observation.
B: peak incidence during adolescence. The highest rates of diagnosis often occur in adolescence, aligning with the hormonal changes and immune responses typical of this developmental period.
C: most of the affected children are asymptomatic. Many individuals with chronic lymphocytic thyroiditis may not exhibit symptoms, leading to a high number of undiagnosed cases in children.
A 10-month-old boy presented with failure to thrive, fever, jaundice, hepatomegaly, and severe rickets. Investigations revealed hypoglycemia and normal anion gap metabolic acidosis. Of the following, the MOST likely enzyme deficiency is
Rationale:
D: fumarylacetoacetate hydrolase deficiency leads to tyrosinemia type I, which can present with failure to thrive, jaundice, and metabolic acidosis. These symptoms align well with the clinical findings in the case presented.
A: acid β-glucosidase deficiency does not cause jaundice or metabolic acidosis, as it is primarily associated with Gaucher disease, which presents differently.
B: β-hexosaminidases deficiency primarily relates to Tay-Sachs disease, characterized by neurodegeneration and not metabolic acidosis or liver involvement, making it unlikely in this scenario.
C: acid sphingomyelinase deficiency is linked to Niemann-Pick disease, which typically presents with splenomegaly and neurological symptoms rather than the combination of liver issues and metabolic acidosis described here.
The MOST appropriate method to confirm the diagnosis of tyrosinemia type 1 is by elevated level of
Rationale:
Elevated level of serum succinylacetone. This metabolite accumulates due to the deficiency of fumarylacetoacetate hydrolase in tyrosinemia type 1, making it a definitive biomarker for diagnosis.
A: α-fetoprotein High levels may indicate liver dysfunction or certain cancers, but they are not specific to tyrosinemia type 1, lacking the diagnostic precision necessary for confirmation.
B: Plasma tyrosine Although elevated in tyrosinemia, plasma tyrosine levels can also be raised in other conditions, thus lacking specificity in confirming tyrosinemia type 1 diagnosis.
C: Serum methionine Elevated serum methionine is associated with other metabolic disorders, such as homocystinuria, and does not provide relevant information for diagnosing tyrosinemia type 1 specifically.
Neonates and young infants with central diabetes insipidus are often best treated with
Rationale:
Fluid therapy effectively addresses the dehydration and electrolyte imbalances in neonates and young infants with central diabetes insipidus, ensuring adequate hydration and maintaining overall health.
B: Vasopressin analogs do not provide the same benefit in neonates, as fluid therapy is more suitable for their age and condition, prioritizing hydration over hormonal treatment.
C: Thiazide diuretics tend to be ineffective in treating central diabetes insipidus in this age group, as they are primarily used for hypertension rather than addressing fluid balance directly.
D: Indomethacin, a non-steroidal anti-inflammatory drug, is not relevant for treating central diabetes insipidus and focuses on other conditions, failing to address the underlying hydration issues present in neonates.
Chronic therapy for the patient in the previous question is best characterized by
Rationale:
Chronic therapy for the patient in the previous question is best characterized by avoiding fasts for longer than 10-12 hours.
This approach helps maintain stable metabolic conditions and prevents potential complications arising from prolonged fasting, ensuring that the patient’s energy levels remain adequate for daily activities and overall health. Consistent glucose availability is crucial in chronic therapy management.
B: high-fat diet This option does not align with chronic therapy objectives, as high-fat diets may exacerbate certain metabolic disorders or lead to detrimental health impacts over time.
C: low-carnitine diet A low-carnitine diet could hinder energy production and exacerbate certain conditions, making it unsuitable for managing chronic therapy effectively in patients requiring adequate energy levels.
D: galactose-free diet While beneficial for specific conditions like galactosemia, a galactose-free diet does not specifically address the broader requirements for chronic therapy in patients needing stable metabolic support.
Cystinuria is a disorder of renal tubular transport of the following amino acids EXCEPT
Rationale:
Cystinuria is a disorder of renal tubular transport of tryptophan. Cystinuria specifically affects the reabsorption of dibasic amino acids, which include cystine, lysine, and arginine, leaving tryptophan unaffected.
A: cystine A key amino acid involved in cystinuria, cystine is directly linked to the disorder’s impaired transport mechanisms in the renal tubules.
B: lysine Like cystine, lysine is a dibasic amino acid affected in cystinuria, indicating its transport impairment is central to the disorder's pathology.
D: arginine Arginine is another dibasic amino acid whose transport is disrupted in cystinuria, distinguishing it from tryptophan, which is not impacted by this condition.
To evaluate the patient in the previous question, all of the following are appropriate EXCEPT
Rationale:
D: Serum 17-hydroxyprogesterone is not appropriate for evaluating the patient since it primarily assesses adrenal function and steroidogenic disorders, rather than the metabolic conditions indicated by the other tests.
A: Serum organic acids provide valuable insights into metabolic abnormalities, making them relevant for evaluation in various conditions, particularly those related to metabolic pathways.
B: Urine carnitine analysis is significant for diagnosing specific metabolic disorders, particularly those involving fatty acid oxidation, thus being pertinent for the patient evaluation.
C: Serum amino acids are crucial for detecting metabolic issues, offering essential information regarding protein metabolism, which is relevant to the patient's overall evaluation.
Levothyroxine (I-T4) given orally is the treatment of choice in congenital hypothyroidism. The recommended initial starting dose is
Rationale:
Levothyroxine (I-T4) given orally is most effectively initiated at a dose of 10-15 µg/kg/day in congenital hypothyroidism. This dosage range ensures adequate thyroid hormone replacement, promoting optimal growth and development in affected infants. Studies support this starting point as it balances efficacy with safety, minimizing the risk of under-treatment or adverse effects.
A: 2-5 µg/kg/day This dosage is insufficient for addressing the severe hormone deficiency present in congenital hypothyroidism, potentially leading to inadequate treatment and ongoing developmental issues.
B: 4-7 µg/kg/day Similarly, this range fails to provide the necessary thyroid hormone levels required for effective management, risking poor growth and cognitive outcomes in affected infants.
C: 5-9 µg/kg/day Although closer, this dosage still does not meet the comprehensive needs of patients with congenital hypothyroidism, which necessitates a higher starting dose for optimal therapy.
The best diagnostic test for the patient in the previous question is
Rationale:
Assay acid β-glucosidase in leukocytes is the best diagnostic test for the patient. This test specifically measures the enzyme deficiency indicative of Gaucher disease, providing clear and direct evidence of the condition's presence when other methods may not offer definitive results.
A: Bone marrow Analyzing the bone marrow primarily assesses hematological conditions, lacking specificity for Gaucher disease, thus making it less suitable for diagnosing the enzyme deficiency involved.
C: Ophthalmoscopy for cherry red spot This method detects retinal changes, which are not exclusive to Gaucher disease and can be found in various other conditions, leading to potential misdiagnosis.
D: Urine long-chain amino acids This test evaluates metabolic disorders rather than directly identifying enzyme deficiencies, rendering it ineffective for diagnosing Gaucher disease specifically and providing limited relevant information.
The 47,XXX (trisomy) chromosomal constitution is the most frequent extra-X chromosome abnormality in females, occurring in almost 1 in 1,000 liveborn females. It is characterized by the following EXCEPT
Rationale:
The 47,XXX chromosomal constitution is characterized by tall and gangly features, normal female phenotype, and maternal meiotic nondisjunction as a common cause; however, sexual development and menarche are typically not delayed.
A: maternal meiotic nondisjunction is the most common cause. This is true, as nondisjunction during maternal meiosis is the leading factor behind the occurrence of the extra X chromosome.
B: normal female phenotype. This reflects the adaptability of the 47,XXX condition, where many individuals present with typical female characteristics despite the chromosomal anomaly.
D: tall and gangly. Individuals with 47,XXX often exhibit increased height and a gangly appearance, which is a recognized physical trait associated with this chromosomal anomaly.
The MOST common electrolyte abnormality in acute intermittent porphyria is
Rationale:
Hyponatremia is the most common electrolyte abnormality in acute intermittent porphyria. This condition often leads to an imbalance in sodium levels, primarily due to the body's response to stress and pain associated with acute attacks.
A: Hyperkalemia Excess potassium levels are not typically associated with acute intermittent porphyria, as sodium dysregulation plays a more significant role in this disorder's clinical presentation.
C: Hypercalcemia Elevated calcium levels do not feature prominently in acute intermittent porphyria, as the primary electrolyte disturbance revolves around sodium rather than calcium metabolism or regulation.
D: Hypomagnesemia Low magnesium levels are not a hallmark of acute intermittent porphyria, with sodium imbalances being the predominant electrolyte issue during acute attacks of the condition.
Many patients with Turner syndrome are recognizable at birth because of
Rationale:
Loose skin folds at the nape of the neck are commonly observed in many patients with Turner syndrome from birth, making them easily recognizable.
The presence of loose skin folds is a notable physical characteristic associated with Turner syndrome, often serving as an initial indicator for diagnosis. This feature, along with others, contributes to the distinct clinical presentation of the condition in affected infants.
B: cubitus valgus This feature pertains to an elbow deformity that develops later in life and is not a recognizable trait at birth in Turner syndrome patients.
C: webbing of the neck While neck webbing can be a characteristic of Turner syndrome, it is less commonly noted immediately at birth compared to loose skin folds.
D: widely spaced nipples Although widely spaced nipples may be associated with Turner syndrome, this trait is not typically evident immediately upon birth and develops with growth.
Matching: For each inborn error of amino acid metabolism, select the correct urine odor - Phenylketonuria
Rationale:
B: Hoplike. Individuals with Phenylketonuria (PKU) have an accumulation of phenylalanine, which leads to a distinctive urine odor reminiscent of hops. This characteristic smell is a key indicator of the metabolic disorder.
A: Cabbage. The cabbage-like odor is typically associated with other conditions, such as certain types of metabolic disorders, but not specifically with Phenylketonuria.
C: Sweaty. A sweaty odor may be linked to other metabolic disorders, but it does not accurately represent the unique urine odor characteristic of Phenylketonuria.
A 5-day-old infant manifests tachypnea, poor feeding, vomiting, and decreased responsiveness. A sepsis workup is performed, and the child is started on a D10W infusion and receives ampicillin and cefotaxime. The condition worsens, and the child becomes unresponsive to stimuli. All cultures are negative after 48 hours. The arterial blood gas is 7.45, PCO2 36, PO2 100, the anion gap is normal, the blood glucose is 75 mg/dL, and serum ammonia is 500 μM. The most likely diagnosis is
Rationale:
B: urea cycle defect. The infant's severe hyperammonemia, coupled with negative cultures and normal blood gases, strongly suggests a metabolic disorder affecting ammonia detoxification, characteristic of urea cycle defects.
A: congenital hyperinsulinism with hyperammonemia. Elevated insulin levels typically lead to hypoglycemia rather than hyperammonemia; the infant's glucose levels are normal, which does not support this diagnosis.
C: methylmalonic acidemia. While metabolic disorders can cause high ammonia levels, this condition usually presents with acidosis and elevated methylmalonic acid, which are not indicated in this case.
D: maple syrup urine disease. This disorder presents with characteristic odor and neurological symptoms, but the absence of specific metabolic markers and normal blood gases makes it an unlikely diagnosis.
A 2-year-old girl presented with rapid deep breathing, hypoglycemia, recurrent epistaxis, easy bruising, failure to thrive, fat cheek, and hepatomegaly. Of the following, the MOST likely cause of bleeding tendency is
Rationale:
Impaired hepatic function is the most likely cause of the bleeding tendency. The girl's symptoms, including hepatomegaly and easy bruising, suggest liver dysfunction, which can lead to inadequate production of clotting factors necessary for hemostasis.
A: vascular disorders. These typically present with different symptoms and do not align with signs of liver disease or the specific bleeding issues observed in this case.
B: clotting factors deficiency. While this could cause bleeding, the combination of symptoms more strongly indicates a liver-related issue rather than a primary deficiency of factors alone.
D: depressed platelets count. Although low platelet counts can lead to bleeding, the girl's hepatomegaly suggests a broader hepatic dysfunction that is more likely responsible for her symptoms.
Acquired hypogonadotropic hypogonadism include
Rationale:
Acquired hypogonadotropic hypogonadism includes chemotherapy. Chemotherapy can disrupt hormonal signaling and testicular function, leading to decreased testosterone production and hypogonadism. This condition reflects the impact of cancer treatments on endocrine health.
B: malnutrition A state of insufficient nutrition does not directly alter hormone signaling but instead affects overall health, potentially leading to secondary hormonal imbalances, not specifically hypogonadotropic hypogonadism.
C: cystic fibrosis This genetic disorder primarily affects the lungs and digestive system, not hormone production or regulation, making it unrelated to the development of acquired hypogonadotropic hypogonadism.
D: infection (e.g., mumps) While infections can impact reproductive health, mumps specifically leads to different forms of testicular damage and does not typically result in hypogonadotropic hypogonadism.
A painless nodule in the thyroid or in the neck is the usual presentation of childhood thyroid cancer. Of the following, the MOST common site of distant metastasis is
Rationale:
D: Lungs. In childhood thyroid cancer, the lungs are the predominant site for distant metastasis, often presenting with asymptomatic lesions that may become evident through imaging or later symptoms.
A: Mediastinum. Although the mediastinum can be affected, it is not the primary location for distant spread in childhood thyroid cancer cases, which typically favors the pulmonary system.
B: Long bones. While long bones can experience metastatic spread, they are not the most common sites for childhood thyroid cancer, which predominantly metastasizes to the lungs instead.
C: Skull. Metastasis to the skull may occur, but it is less frequent than lung involvement, making it an unlikely choice for the most common site of distant spread.
Matching: Glycogen storage diseases - Pompe
Rationale:
Pompe disease is characterized by cardiomegaly and hypotonia, which arise due to glycogen accumulation in tissues, particularly affecting the heart and skeletal muscles. These symptoms are crucial for diagnosis and management of the condition.
A: Muscle cramps, exercise intolerance. These symptoms are more associated with other glycogen storage diseases, such as McArdle disease, rather than specifically linked to Pompe disease.
B: Severe hypoglycemia, hepatomegaly. These features are typical of diseases like von Gierke's disease, not Pompe, which primarily affects cardiac and muscular function rather than glucose metabolism.
D: Progressive early cirrhosis, failure to thrive. This description pertains to conditions affecting the liver, such as Wilson's disease, rather than the specific manifestations seen in Pompe disease.
Patients with mineralocorticoid deficiency can develop the following EXCEPT
Rationale:
Patients with mineralocorticoid deficiency can develop metabolic alkalosis. This condition typically arises from excessive potassium loss, which is not a direct consequence of mineralocorticoid deficiency, making it the exception among the listed options.
A: weight loss Excessive fluid loss and hormonal imbalances associated with mineralocorticoid deficiency often lead to significant weight loss in affected patients.
B: hypotension A lack of mineralocorticoids results in reduced sodium retention, contributing to decreased blood volume and consequently, hypotension in patients.
D: hyponatremia Insufficient mineralocorticoids cause impaired sodium retention, leading to low sodium levels, known as hyponatremia, which is a common complication.
Matching: Peroxisomal disorder
Rationale:
Peroxisomal disorder. This term comprehensively describes a group of genetic conditions characterized by dysfunctional peroxisomes, which are critical for lipid metabolism and various biochemical processes in the body.
B: Disorder of peroxisomal import. This option refers specifically to a subset of peroxisomal disorders, rather than encompassing the broader category indicated by the correct answer.
C: X-linked. This choice inaccurately identifies a genetic pattern that may apply to some disorders but does not specifically define peroxisomal disorders as a whole.
D: Primarily African-American. This statement generalizes a demographic aspect that does not accurately represent the diverse range of individuals affected by peroxisomal disorders globally.
The percentage of individuals with congenital heart defects is highest in
Rationale:
B: The percentage of individuals with congenital heart defects is highest in Williams syndrome. This syndrome is characterized by a high prevalence of cardiovascular anomalies, particularly aortic stenosis and supravalvular aortic stenosis, making it notable for these defects.
A: Turner syndrome features a range of physical anomalies but has a lower prevalence of congenital heart defects compared to Williams syndrome, focusing more on other developmental issues.
C: Down syndrome exhibits congenital heart defects, notably atrioventricular septal defects, but the incidence is not as elevated as seen in Williams syndrome, which presents a broader range of cardiac anomalies.
D: Cri du Chat syndrome has various associated medical issues, yet congenital heart defects are not as common in this condition compared to the significantly higher rates observed in Williams syndrome.
A 6-week-old infant has gained no weight since birth. She is mottled and has an indirect bilirubin level of 24 mg/dL. Her extremities are cold, and her temperature is 35°C. The most likely diagnosis is
Rationale:
Hypothyroidism. The infant's failure to gain weight, cold extremities, low temperature, and high bilirubin levels suggest a metabolic disorder like hypothyroidism, which can severely affect growth and development in newborns.
A: kernicterus. This condition refers to bilirubin-induced neurological damage and typically occurs with elevated bilirubin levels, but does not account for the infant's overall clinical presentation and lack of weight gain.
B: sepsis. While sepsis can cause poor weight gain and temperature instability, the specific combination of symptoms presented aligns more closely with hypothyroidism rather than a systemic infection.
C: galactosemia. This metabolic disorder causes difficulties in processing galactose, leading to symptoms like jaundice and poor weight gain, but the overall clinical picture is more indicative of hypothyroidism.
A 12-year-old female has a hypoglycemic seizure, weakness, and increased cutaneous pigmentation. She is also noted to have a chronic history of mucocutaneous candidiasis, which is especially severe on her nails. In addition, she has been on thyroid replacement medication since the age of 9 years. The most likely diagnosis is
Rationale:
Autoimmune polyendocrinopathy. This diagnosis aligns with the patient's symptoms of hypoglycemic seizures, mucocutaneous candidiasis, and chronic thyroid issues, suggesting an underlying autoimmune disorder affecting multiple endocrine glands.
A: insulinoma. This condition typically presents with recurrent hypoglycemia but lacks the other systemic symptoms like candidiasis and thyroid dysfunction that are evident in this patient.
B: growth hormone deficiency. While it may cause growth issues, it does not explain the hypoglycemic seizures, candidiasis, or chronic thyroid medication history highlighted in this case.
C: AIDS. Although immunodeficiency can lead to candidiasis, the specific endocrine symptoms and seizure activity do not correlate with an HIV-related diagnosis as seen in this patient.
Reported side effects of GH treatment include the following EXCEPT
Rationale:
Reported side effects of GH treatment include pseudotumor cerebri, slipped capital femoral epiphysis, and gynecomastia, but not a 6-fold increase in the risk for type 1 diabetes.
D is not associated with growth hormone treatment, as studies have shown no significant correlation between GH therapy and an elevated risk for developing type 1 diabetes in patients.
A: pseudotumor cerebri This condition has been documented as a potential side effect of growth hormone therapy, indicating an increased intracranial pressure linked to GH treatment.
B: slipped capital femoral epiphysis Associated with growth hormone use, this condition involves the displacement of the femoral head and is a recognized risk during GH therapy.
C: gynecomastia This side effect occurs due to hormonal changes induced by growth hormone treatment, leading to breast tissue enlargement in males, confirming its relevance as a side effect.
The following criteria are needed for the diagnosis of syndrome of inappropriate secretion of antidiuretic hormone (SIADH) EXCEPT
Rationale:
Hyponatremia with normal serum osmolality is not a criterion for diagnosing SIADH. In SIADH, hyponatremia typically occurs alongside low serum osmolality, indicating an abnormal retention of water rather than a normal physiological state.
A: excessive urinary sodium concentration This condition characterizes SIADH, as high urinary sodium often results from excess water retention and inappropriate secretion of antidiuretic hormone.
C: elevated urine osmolality Elevated urine osmolality is a hallmark of SIADH, demonstrating the kidneys' inability to excrete dilute urine despite low serum sodium levels.
D: normal renal, adrenal, and thyroid function Diagnosis of SIADH requires the exclusion of other causes, so normal function of these systems is essential for confirming the syndrome.
A 16-year-old male has a tall stature but no facial, axillary, or pubic hair. His penis and scrotum are obscured by pubic adipose tissue, but they appear infantile. Chromosome analysis reveals XY karyotype. His serum follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels are elevated. The most likely diagnosis is
Rationale:
Primary hypogonadism is the most likely diagnosis. The elevated FSH and LH levels indicate that the testes are not responding adequately, leading to insufficient testosterone production and resulting in the observed delayed puberty and infantile genitalia.
A: galactosemia This condition primarily affects carbohydrate metabolism and does not relate to sexual development or hormone levels, making it irrelevant to the patient's symptoms of delayed sexual maturation.
C: adrenal hyperplasia This disorder involves abnormal adrenal hormone production, typically leading to virilization. However, the lack of secondary sexual characteristics and elevated FSH and LH suggest primary hypogonadism instead.
D: Noonan syndrome While this genetic disorder can present with short stature and undescended testes, it does not specifically explain the elevated gonadotropins or the complete absence of secondary sexual characteristics.
Hypocalcemia is common in neonates between 12 and 72 hr of life, especially in infants with
Rationale:
Hypomagnesemia is a common condition in neonates between 12 and 72 hours of life, often leading to hypocalcemia due to its role in regulating calcium levels and facilitating parathyroid hormone activity.
A: birth asphyxia Infants experiencing birth asphyxia may have metabolic disturbances, but this condition does not directly cause hypocalcemia through magnesium levels.
B: sepsis While sepsis can lead to various metabolic imbalances, it is not specifically linked to hypocalcemia through magnesium deficiency in neonates.
C: exchange transfusion Exchange transfusions are typically used to manage conditions like hemolytic disease and do not have a direct connection to causing hypocalcemia related to magnesium levels.
All the following drugs are unsafe in acute intermittent porphyria EXCEPT
Rationale:
Nifedipine is the only drug that is considered safe in acute intermittent porphyria. It does not exacerbate the condition or interfere with heme synthesis, making it an appropriate choice for patients.
B: Diclofenac can trigger porphyric crises, as it may affect heme metabolism and lead to increased levels of porphyrins, worsening the patient's condition.
C: Cimetidine has the potential to disrupt heme synthesis, which can provoke acute symptoms in individuals with porphyria, leading to complications in their management.
D: Valproic acid is known to induce porphyric episodes, as it can interfere with metabolic pathways related to heme production, posing risks for patients suffering from acute intermittent porphyria.
All the following are features of neonatal adrenoleukodystrophy (ALD) EXCEPT
Rationale:
D: Chondrodysplasia punctata
Neonatal adrenoleukodystrophy (ALD) primarily affects the nervous system and adrenal glands, leading to symptoms such as hepatomegaly, impaired liver function, and hearing loss, but does not include chondrodysplasia punctata, which is unrelated.
A: hepatomegaly
Hepatomegaly is a common manifestation in neonatal ALD, resulting from the accumulation of very long-chain fatty acids that disrupt normal liver function and structure.
B: impaired liver function
Impaired liver function occurs in neonatal ALD due to the toxic effects of accumulated fatty acids, which compromise liver cells and disrupt metabolic processes critical for health.
C: severely impaired hearing
Severely impaired hearing can develop in neonatal ALD as a result of neurological degeneration affecting auditory pathways, underscoring the disorder's impact on sensory functions.
You are going to treat a 7-year-old boy with type 1 diabetes mellitus who develops DKA due to a recent infection. Examination reveals severe dehydration and deep acidotic breathing. Lab investigations shows: blood glucose, 450 mg/dL; blood pH, 7.2; and serum bicarbonate concentration, 14 mEq/L. Which of the following should be avoided during the treatment of this girl?
Rationale:
C: Bicarbonate administration is contraindicated in DKA management, especially in children, as it may lead to paradoxical cerebral acidosis, worsening the condition. The primary treatment focuses on fluid resuscitation and insulin therapy to correct acidosis and hyperglycemia.
A: Lactated Ringer solution may not be suitable as its lactate content can interfere with the body's acid-base balance during acute DKA management.
B: Glucose should not be introduced until the patient's levels stabilize, as it can exacerbate hyperglycemia and prolong the DKA state, complicating recovery.
D: Fast-acting soluble insulin is essential in DKA treatment, rapidly reducing blood glucose levels, so avoiding it would hinder effective management and recovery from the condition.
Chronic lymphocytic thyroiditis is the most common cause of acquired hypothyroidism, with or without goiter. All the following are true EXCEPT
Rationale:
Chronic lymphocytic thyroiditis is characterized by a variable clinical course, often fluctuating over time rather than remaining constant. This variability can lead to periods of both increased and decreased thyroid function in affected individuals.
A: more common in girls. This condition is statistically more prevalent among females, indicating a gender predisposition that aligns with autoimmune disorders generally affecting women more frequently.
B: peak incidence during adolescence. Research indicates that the highest occurrence of chronic lymphocytic thyroiditis is noted in adolescence, correlating with hormonal changes and immune system development during this life stage.
C: most of the affected children are asymptomatic. Many children with chronic lymphocytic thyroiditis do not exhibit noticeable symptoms, often leading to delayed diagnosis despite having underlying thyroid dysfunction.
A 10-month-old boy presented with failure to thrive, fever, jaundice, hepatomegaly, and severe rickets. Investigations revealed hypoglycemia and normal anion gap metabolic acidosis. Of the following, the MOST likely enzyme deficiency is
Rationale:
D. Fumarylacetoacetate hydrolase deficiency leads to tyrosinemia type I, causing severe liver dysfunction, rickets, and failure to thrive in infants. The accompanying metabolic acidosis and hypoglycemia further support this enzyme's role in metabolic pathways, indicating its deficiency as the underlying cause of the symptoms.
A: Acid β-glucosidase does not correlate with the presented clinical symptoms, which are more indicative of a metabolic disorder rather than lysosomal storage disease, where this enzyme is involved.
B: β-Hexosaminidases are associated with Tay-Sachs disease, which primarily affects neurological function rather than liver dysfunction or metabolic acidosis shown in this case, making this option unsuitable.
C: Acid sphingomyelinase deficiency causes Niemann-Pick disease, characterized by splenomegaly and neurological symptoms, rather than the specific combination of jaundice, rickets, and metabolic acidosis observed in the patient.
The MOST appropriate method to confirm the diagnosis of tyrosinemia type 1 is by elevated level of
Rationale:
Elevated level of serum succinylacetone is the most appropriate method to confirm the diagnosis of tyrosinemia type 1. This compound accumulates due to the deficiency of fumarylacetoacetate hydrolase, which is characteristic of the disease, thus serving as a reliable biomarker for diagnosis.
A: α-fetoprotein This biomarker is associated with hepatocellular carcinoma and certain liver conditions, not specifically linked to tyrosinemia type 1 diagnosis, making it unsuitable for confirming this particular disorder.
B: plasma tyrosine Although elevated plasma tyrosine levels can indicate tyrosinemia, they are not exclusive to type 1 and thus lack the specificity needed for a definitive diagnosis.
C: serum methionine Elevated serum methionine levels are typically associated with disorders like homocystinuria, not tyrosinemia type 1, leading to misinterpretation of the metabolic profile in this context.
Neonates and young infants with central diabetes insipidus are often best treated with
Rationale:
Fluid therapy effectively addresses the hydration needs of neonates and young infants suffering from central diabetes insipidus, ensuring they maintain appropriate fluid balance and preventing dehydration-related complications.
B: Vasopressin analogs do not target the underlying issues in neonates with central diabetes insipidus, making them less suitable for this patient population, especially in early treatment stages.
C: Thiazide diuretics primarily reduce urine output by promoting sodium and water reabsorption, which is not the optimal approach for managing central diabetes insipidus in infants.
D: Indomethacin, an anti-inflammatory medication, lacks efficacy in treating central diabetes insipidus in neonates and may introduce unnecessary risks without addressing fluid management needs.
Chronic therapy for the patient in the previous question is best characterized by
Rationale:
Chronic therapy for the patient is best characterized by avoiding fasts for longer than 10-12 hours. This approach helps to maintain stable metabolic function and prevent complications associated with prolonged fasting.
B: high-fat diet This option does not address the need for managing fasting periods, which is critical for maintaining metabolic stability in chronic therapy.
C: low-carnitine diet While a low-carnitine diet might be relevant in specific conditions, it does not pertain to the management of fasting durations essential for chronic therapy.
D: galactose-free diet A galactose-free diet is important for managing certain metabolic disorders but does not relate to the avoidance of extended fasting periods necessary for chronic care.
Cystinuria is a disorder of renal tubular transport of the following amino acids EXCEPT
Rationale:
Cystinuria is a disorder of renal tubular transport of tryptophan. This amino acid is not typically associated with cystinuria, which primarily affects the transport of dibasic amino acids like cystine, lysine, and arginine.
A: cystine Cystinuria specifically involves impaired transport of cystine, making it a central focus of the disorder's pathology and directly related to its clinical manifestations.
B: lysine Lysine, being a dibasic amino acid, is one of the amino acids affected by cystinuria, contributing to the disorder's characteristic urine composition and symptoms.
D: arginine Arginine is also categorized as a dibasic amino acid affected by cystinuria, impacting renal tubular function and leading to elevated levels in the urine.
To evaluate the patient in the previous question, all of the following are appropriate EXCEPT
Rationale:
D: Serum 17-hydroxyprogesterone is not appropriate for evaluating the patient as it primarily assesses adrenal function and steroidogenesis rather than metabolic disorders linked to organic acids, carnitine, or amino acids.
A: Serum organic acids provide valuable insights into metabolic pathways and can indicate specific disorders, making them essential for evaluation in a metabolic context.
B: Urine carnitine levels are critical for assessing fatty acid oxidation disorders, providing necessary information for understanding the patient's metabolic state and potential deficiencies.
C: Serum amino acids are integral in diagnosing metabolic disorders, offering a direct link to protein metabolism and potential deficiencies that may be crucial for patient evaluation.
Levothyroxine (I-T4) given orally is the treatment of choice in congenital hypothyroidism. The recommended initial starting dose is
Rationale:
Levothyroxine (I-T4) given orally is the treatment of choice in congenital hypothyroidism, with the recommended initial starting dose being 10-15 µg/kg/day. This dosage ensures that adequate thyroid hormone levels are achieved to support normal growth and development in infants diagnosed with congenital hypothyroidism, preventing complications associated with insufficient hormone production.
A: 2-5 µg/kg/day This dosage is significantly lower than the recommended starting range, which may lead to inadequate thyroid hormone levels and result in developmental delays or other health issues.
B: 4-7 µg/kg/day Although closer to the correct range, this option still falls short of the necessary dosage that ensures optimal treatment outcomes in infants with congenital hypothyroidism.
C: 5-9 µg/kg/day This choice does not meet the established guidelines, as it remains below the recommended starting dose, potentially resulting in insufficient hormone replacement and adverse effects on growth and development.
The best diagnostic test for the patient in the previous question is
Rationale:
Assay acid β-glucosidase in leukocytes is the best diagnostic test for the patient. This test specifically measures the enzyme deficiency associated with Gaucher disease, providing a definitive diagnosis through targeted enzyme analysis in relevant cells.
A: bone marrow Analysis of bone marrow does not directly assess enzyme activity, making it less specific for diagnosing conditions like Gaucher disease compared to the leukocyte enzyme assay.
C: ophthalmoscopy for cherry red spot While a cherry-red spot can indicate certain conditions, it does not provide a specific diagnosis of Gaucher disease and lacks sensitivity for enzyme-related disorders.
D: urine long-chain amino acids Urine testing for long-chain amino acids does not correlate with Gaucher disease, as it primarily assesses metabolic disorders unrelated to the specific enzyme deficiency in this context.
The 47,XXX (trisomy) chromosomal constitution is the most frequent extra-X chromosome abnormality in females, occurring in almost 1 in 1,000 liveborn females. It is characterized by the following EXCEPT
Rationale:
Trisomy 47,XXX does not typically delay sexual development and menarche; instead, affected individuals generally experience normal sexual maturation. This characteristic distinguishes it from other chromosomal abnormalities that often involve such delays.
A: maternal meiotic nondisjunction is the most common cause. This is a recognized origin of 47,XXX, as errors during maternal meiosis frequently lead to chromosomal abnormalities in offspring.
B: normal female phenotype. Individuals with 47,XXX usually present a typical female phenotype, with few visible features distinguishing them from the general population, maintaining normal physical characteristics.
D: tall and gangly. While some affected individuals may be taller than average, they do not universally exhibit a tall and gangly physique; physical traits vary significantly among individuals.
The MOST common electrolyte abnormality in acute intermittent porphyria is
Rationale:
Hyponatremia is the most common electrolyte abnormality in acute intermittent porphyria. This condition often leads to sodium imbalances due to factors such as fluid shifts and hormonal changes affecting sodium retention and excretion.
A: Hyperkalemia Elevated potassium levels are not typically associated with acute intermittent porphyria and do not reflect the primary electrolyte disturbance observed in this condition.
C: Hypercalcemia Increased calcium levels do not correlate with acute intermittent porphyria's clinical presentation and are not a recognized electrolyte abnormality in this disorder.
D: Hypomagnesemia Low magnesium levels do not represent the common electrolyte issue in acute intermittent porphyria and are less frequently reported in relation to this condition's pathophysiology.
Many patients with Turner syndrome are recognizable at birth because of
Rationale:
Many patients with Turner syndrome are recognizable at birth because of loose skin folds at the nape of the neck. This characteristic is a notable physical feature seen in many infants with Turner syndrome, often leading to early diagnosis and recognition of the condition. The presence of these folds contributes significantly to the clinical presentation at birth.
B: cubitus valgus This condition refers to an angle at the elbow that is greater than normal, which does not typically manifest at birth and is not a distinctive feature of Turner syndrome.
C: webbing of the neck Although neck webbing can be associated with Turner syndrome, loose skin folds at the nape are more commonly observed at birth, making it a more recognizable feature.
D: widely spaced nipples This characteristic is often seen in Turner syndrome but is not generally apparent at birth, making it less recognizable than the loose skin folds at the nape of the neck.